tisagenlecleucel
novartis
['fil,veral,12', 'nhl', 'tocilizumab', 'toci', 'tisa-cel', 'tisagenlecleucel']
#ash22
abstract 656 - daniel landsburg et al. real world data of tisa-cel for r/r lbcl from registry. efficacy and safety outcomes remain consistent with earlier data cuts. cr 44.5%
2-year pfs 28.4%
2-year os 43.6%
grade 3-4 crs 6%
grade 3-4 icans 7% 
Hematologist at Saint Antoine Hospital, Paris, France @Sorbonne_Univ_ @APHP. @JACIE_EBMT National Representative. #BMTsm #LYMsm #CARTcell #CardioOnc #QoL